This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of Tong-Ming Fu in Hepatitis C Research.
Introduction
Tong-Ming Fu is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic hepatitis C genes. His work has implications for vaccine development and therapeutic strategies against hepatitis C virus (HCV).
Latest Patents
Tong-Ming Fu holds a patent for synthetic hepatitis C genes. The patent describes polynucleotides that comprise a DNA sequence encoding an HCV protein and fragments optimized for expression in a vertebrate host. The uses of these polynucleotides include eliciting an immune response specifically recognizing HCV.
Career Highlights
Fu is associated with Merck & Co., Inc., a leading global healthcare company. His role at Merck has allowed him to work on groundbreaking research that addresses critical health challenges posed by viral infections.
Collaborations
Some of his notable coworkers include John J. Donnelly and Margaret A. Liu. Their collaborative efforts contribute to the advancement of research in the field of infectious diseases.
Conclusion
Tong-Ming Fu's innovative work in synthetic hepatitis C genes exemplifies the importance of research in combating viral infections. His contributions are vital for the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile